Brief: Cocrystal Pharma Q3 Net Income USD -4.165 Million
13/11/2023 13:00
Nov 13 (Reuters) - Cocrystal Pharma Q3 operating expenses USD 4.443 million. * Q3 basic EPS USD -0.41 * Q3 operating income USD -4.443 million
Recent news on Cocrystal Pharma
See all newsBrief: Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Human Challenge Study Evaluating CDI-988 For Norovirus Prevention And Treatment
Cocrystal Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Cocrystal Pharma Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway